Jacob Gehrman
Papers
1
Total Citations
87
H-Index
1
About
Jacob Gehrman is a leading health economist whose research focuses on the economic evaluation of surgical technologies, particularly in oncological care. His most influential work centers on the cost-effectiveness of robot-assisted laparoscopic surgery versus open procedures for prostate cancer, a field where rapid technological adoption has often outpaced rigorous economic analysis. Gehrman’s landmark study within the prospective multicentre LAPPRO trial (cited 87 times) provided critical, evidence-based insights into the financial implications of robotic surgery, revealing that while robot-assisted laparoscopic prostatectomy offers clinical benefits, it also introduces significantly higher costs without proportional improvements in all patient outcomes. This work has shaped policy discussions and hospital budgeting decisions worldwide, underscoring the need for value-based healthcare. Beyond this, Gehrman’s broader contributions include developing methodologies for integrating health economic modeling into large-scale clinical trials, ensuring that cost data are as robust as clinical endpoints. His research continues to influence how surgeons, hospital administrators, and insurers weigh the trade-offs between innovation and affordability in surgical oncology.
Research Focus
Key Achievements
Top Papers
- 1